Citius Oncology CTOR
NASDAQ CTOR
$0.76 +0.01 (+0.98%)
At close: Aug 20, 2026 · 2:44 PM UTC

Citius Oncology (CTOR) Total Debt (2021)

Citius Oncology (CTOR) Total Debt (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -5.81 Bn
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 16.59 Bn
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn 9.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn 31.47 Bn
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 13.35 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn -
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 3.92 Bn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - 760.00 Mn
10 Citius Oncology 81.99 Mn 81.99 Mn 1.00 Mn 3.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 130,687.00